Lexaria Bioscience Corp. — Director's Dealing 2015

Dec 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-09-16

Reporting Person: McKechnie William Edward (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-16	Common Shares	A	10000	—	Acquired	110000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-16	Stock Options	$0.17	A	10000	Acquired	2020-09-16	Common Shares (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	100000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.17	2020-09-16	Common Shares (100000)	100000	Direct

Footnotes

F1: Adjusted to forward 1.1 split

F2: Adjusted price to forward 1.1 split